Journal
CURRENT MEDICINAL CHEMISTRY
Volume 27, Issue 17, Pages 2779-2791Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867326666190620110732
Keywords
Colorectal cancer; metastases; prognostic factors; predictive factors; biologic therapy; chemotherapy
Ask authors/readers for more resources
Colorectal cancer represents the third most frequently occurring cancer worldwide. In the last decade, the survival of patients affected by metastatic colorectal cancer (mCRC) has improved through the introduction of biological drugs. However, in this new and dynamic therapeutic context, research about prognostic and predictive factors is important to guide the oncologists to effective therapies as well as to improve the understanding of colorectal cancer biology. Their identification is an intensive area of research and our future goal will be to depict tumour-specific molecular signatures in order to predict the clinical course of the disease and the best treatments. In this report, we describe clinical, pathological and molecular biomarkers that can play a role as prognostic or predictive factors in mCRC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available